Shanghai-based asset manager Yingke PE has set up two new funds with a total target corpus of 1 billion yuan ($156.8 million) as it seeks to expand its portfolio of almost 300 biopharmaceutical and hard tech companies.
Yingke PE, which manages over 50 billion yuan ($7.8 billion) in assets, said in a statement on Thursday that it is raising the capital from institutional investors, including biopharmaceutical companies, local governments, and insurance firms.
